Noa Stettner

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas et al. · Cell · 2022 · 465 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Phage Consortia +10

Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis

Shiran Rabinovich, Lital N. Adler, Keren Yizhak et al. · Nature · 2015 · 378 citations

Ass1-deficient Tumours Fosters, Endocrine-related Cancer, Oncogenic Agent +9

Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance

Jotham Suez, Yotam Cohen, Rafael Valdés‐Mas et al. · Cell · 2022 · 332 citations

Nutrition, Dysbiosis, Precision Nutrition +8

Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures

Joo Sang Lee, Lital N. Adler, Hiren Karathia et al. · Cell · 2018 · 283 citations · Full text

Urology, Biochemical Signatures, Renal Function +7

Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors

Rom Keshet, Joo Sang Lee, Lital N. Adler et al. · Nature Cancer · 2020 · 97 citations

Purine Synthesis, Checkpoint Inhibitors, Medicine +9